| About the author: |
R. L. Stepanenko, M. O. Dudchenko, V. I. Stepanenko, K. V. Vasylyeva, V. I. Kameniev, S. G. Svirid, T. O. Litinska |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
Psoriasis is one of the most common dermatoses and occupies one of the leading places among the current problems of modern dermatology. 148 patients were involved in the study. Comparative evaluation of the therapeutic efficacy of monotherapy with the immunobiological drug Adalimumab, as well as its combination with a domestic non-hormonal drug based on natural ingredients (Flaxseed oil, Solidol fatty, D-panthenol, Allantoin, Herd extract, Celandine acid extract, Celandine extract) in the examined patients with psoriasis vulgaris was performed according to the dynamics of regression of cutaneous clinical manifestations of dermatosis: reduction of lesion area, regression of erythema, infiltration, peeling of psoriatic skin rash, changes in PASI, PGA, BSA index. We have proposed a modified treatment regimen for patients with psoriasis vulgaris, which provides a course of systemic immunobiological therapy with adalimumab with concomitant use of domestic non-hormonal drug can increase the effectiveness of treatment and prolong the remission of dermatosis. |
| Tags |
psoriasis, features of lipid metabolism, immunopathogenesis, immunobiological therapy |
| Bibliography |
- Bilovol AM, Nikolayev VB, Haluzynska LV. Stan reaktyvnosti spoluchnoyi tkanyny u khvorykh na poshyrenyy psoriaz. Ukr. zhurn. dermatol., venerol., kosmetol. 2017; 1 (14): 14–17. [in Ukrainian]
- Armstrong AW, Harskamp CT, Armstrong EJ. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013 Apr; 68(4):654–662. doi: 10.1016/j.jaad.2012.08.015.
- Harrington CL, Dey AK, Yunus R, Joshi AA, Mehta NN. Psoriasis as a human model of disease to study inflammatory atherogenesis. Am J Physiol Heart Circ Physiol. 2017 May 1; 312(5): 867–873. doi: 10.1152/ajpheart.00774.2016.
- Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol. 2012 Jul; 67(1):76–85. doi: 10.1016/j.jaad.2011.06.035.
- Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012 Mar; 132(3 Pt 1):556–62. doi: 10.1038/jid.2011.365.
- Rendon A, Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci. 2019 Mar 23; 20(6):1475. doi: 10.3390/ijms20061475.
- Snast I, Reiter O, Atzmony L, Leshem YA, Hodak E, Mimouni D, et al. Psychological stress and psoriasis: a systematic review and meta-analysis. Br J Dermatol. 2018 May; 178(5):1044–1055. doi: 10.1111/bjd.16116.
- Wang SH, Yuan SG, Peng DQ, Zhao SP. HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells. Atherosclerosis. 2012 Nov; 225(1):105–14. doi: 10.1016/j.atherosclerosis.2012.07.029.
- Yang EJ, Beck KM, Sanchez IM, Koo J, Liao W. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis (Auckl). 2018 Aug 28; 8:41–47. doi: 10.2147/PTT.S169389.
- Yeung H, Takeshita J, Mehta NN, Kimmel SE, Ogdie A, Margolis DJ, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013 Oct; 149(10):1173–9. doi: 10.1001/jamadermatol.2013.5015.
|
| Publication of the article |
«World of Medicine and Biology» №2(80), 2022 year, 156-161 pages, index UDK 616.517-092:577.121 |
| DOI |
10.26724/2079-8334-2022-2-80-156-161 |
